Evidence map›Paper›PMID 41113560›Full record

ArticleFrontiers in pediatrics2025

Clinical value of C-reactive protein to albumin ratio, aspartate aminotransferase, and platelet-to-lymphocyte ratio in predicting the severity of community-acquired pneumonia in children.

Bo Han, Xiang Li, Lu Zhang, Hao Zhang, Bo Wang

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bo HanDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Anhui, China.
Xiang LiDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Anhui, China.
Lu ZhangFaculty of Medicine, Macau University of Science and Technology, Macau, China.
Hao ZhangThe Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Bo WangDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/objectives: Community-Acquired Pneumonia (CAP) is a common acute and critical illness in pediatrics and one of the leading causes of death in hospitalized children worldwide. Inflammatory mechanisms play a significant role in pneumonia, and inflammatory markers have shown value in predicting severity in various diseases. This study aimed to explore the predictive value of key inflammatory markers for identifying the severity of pediatric CAP. Methods: A retrospective analysis was conducted on children with CAP, comparing inflammatory markers between mild and severe pneumonia groups. Markers analyzed included Platelet-to-Lymphocyte Ratio (PLR), Aspartate Aminotransferase (AST), and C-Reactive Protein to Albumin Ratio (CAR). Statistical analyses involved group comparisons using appropriate tests for continuous and categorical variables, multivariate logistic regression to identify independent risk factors, and receiver operating characteristic (ROC) curves to evaluate predictive performance ( Results: A total of 303 children were included; 87 with severe pneumonia and 216 with mild pneumonia. Severe cases showed significantly higher levels of CAR (24.52 vs. 0.19 mg/L, Conclusions: High levels of CAR, AST, and PLR are significantly associated with the presence of severe pneumonia in children with CAP and can serve as effective predictive indicators for identifying disease severity and guiding clinical assessment of disease progression.

Indexed as

community-acquired pneumoniaC-reactive protein to albumin ratioinflammatory markersrisk factorssevere pneumonia

Identifiers

PMID41113560
PMCPMC12531026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.